PL361934A1 - Excitatory amino acid receptor antagonists - Google Patents
Excitatory amino acid receptor antagonistsInfo
- Publication number
- PL361934A1 PL361934A1 PL01361934A PL36193401A PL361934A1 PL 361934 A1 PL361934 A1 PL 361934A1 PL 01361934 A PL01361934 A PL 01361934A PL 36193401 A PL36193401 A PL 36193401A PL 361934 A1 PL361934 A1 PL 361934A1
- Authority
- PL
- Poland
- Prior art keywords
- amino acid
- receptor antagonists
- acid receptor
- excitatory amino
- excitatory
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/06—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/06—Antimigraine agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
Landscapes
- Health & Medical Sciences (AREA)
- Organic Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- General Health & Medical Sciences (AREA)
- Neurology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Biomedical Technology (AREA)
- Medicinal Chemistry (AREA)
- Neurosurgery (AREA)
- Pain & Pain Management (AREA)
- Hospice & Palliative Care (AREA)
- Psychiatry (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Plural Heterocyclic Compounds (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US26001401P | 2001-01-05 | 2001-01-05 | |
| PCT/US2001/044715 WO2002053561A1 (en) | 2001-01-05 | 2001-12-20 | Excitatory amino acid receptor antagonists |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| PL361934A1 true PL361934A1 (en) | 2004-10-18 |
Family
ID=22987455
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| PL01361934A PL361934A1 (en) | 2001-01-05 | 2001-12-20 | Excitatory amino acid receptor antagonists |
Country Status (23)
| Country | Link |
|---|---|
| EP (1) | EP1351955A1 (es) |
| JP (1) | JP2004520335A (es) |
| KR (1) | KR20030066797A (es) |
| CN (1) | CN1484642A (es) |
| AR (1) | AR035679A1 (es) |
| BR (1) | BR0116672A (es) |
| CA (1) | CA2431545A1 (es) |
| CZ (1) | CZ20031856A3 (es) |
| DZ (1) | DZ3460A1 (es) |
| EA (1) | EA200300770A1 (es) |
| EC (1) | ECSP034682A (es) |
| HR (1) | HRP20030544A2 (es) |
| HU (1) | HUP0302528A2 (es) |
| IL (1) | IL156138A0 (es) |
| MX (1) | MXPA03005981A (es) |
| NO (1) | NO20032973L (es) |
| NZ (1) | NZ525821A (es) |
| PE (1) | PE20020792A1 (es) |
| PL (1) | PL361934A1 (es) |
| SK (1) | SK8242003A3 (es) |
| TW (1) | TW591023B (es) |
| WO (1) | WO2002053561A1 (es) |
| ZA (1) | ZA200304311B (es) |
Family Cites Families (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5284957A (en) * | 1992-09-03 | 1994-02-08 | Eli Lilly And Company | Excitatory amino acid receptor antagonists |
| IL137684A0 (en) * | 1998-02-06 | 2001-10-31 | Smithkline Beechmam Plc | Salts of paroxetine |
| GB9908175D0 (en) * | 1999-04-09 | 1999-06-02 | Lilly Co Eli | Method of treating neurological disorders |
| DK1200073T3 (da) * | 1999-07-06 | 2007-05-07 | Lilly Co Eli | Selektive iGluR5-receptorantagonister til behandling af migræne |
-
2001
- 2001-12-20 CA CA002431545A patent/CA2431545A1/en not_active Abandoned
- 2001-12-20 KR KR10-2003-7008977A patent/KR20030066797A/ko not_active Application Discontinuation
- 2001-12-20 EA EA200300770A patent/EA200300770A1/ru unknown
- 2001-12-20 DZ DZ013460A patent/DZ3460A1/fr active
- 2001-12-20 CZ CZ20031856A patent/CZ20031856A3/cs unknown
- 2001-12-20 SK SK824-2003A patent/SK8242003A3/sk unknown
- 2001-12-20 HU HU0302528A patent/HUP0302528A2/hu unknown
- 2001-12-20 MX MXPA03005981A patent/MXPA03005981A/es unknown
- 2001-12-20 PL PL01361934A patent/PL361934A1/xx not_active Application Discontinuation
- 2001-12-20 NZ NZ525821A patent/NZ525821A/en unknown
- 2001-12-20 BR BR0116672-7A patent/BR0116672A/pt not_active IP Right Cessation
- 2001-12-20 EP EP01995980A patent/EP1351955A1/en not_active Withdrawn
- 2001-12-20 IL IL15613801A patent/IL156138A0/xx unknown
- 2001-12-20 JP JP2002554680A patent/JP2004520335A/ja active Pending
- 2001-12-20 WO PCT/US2001/044715 patent/WO2002053561A1/en not_active Application Discontinuation
- 2001-12-20 CN CNA018217508A patent/CN1484642A/zh active Pending
-
2002
- 2002-01-04 TW TW091100071A patent/TW591023B/zh not_active IP Right Cessation
- 2002-01-04 AR ARP020100030A patent/AR035679A1/es not_active Application Discontinuation
- 2002-01-04 PE PE2002000003A patent/PE20020792A1/es not_active Application Discontinuation
-
2003
- 2003-06-02 ZA ZA200304311A patent/ZA200304311B/en unknown
- 2003-06-27 NO NO20032973A patent/NO20032973L/no not_active Application Discontinuation
- 2003-07-03 HR HR20030544A patent/HRP20030544A2/hr not_active Application Discontinuation
- 2003-07-03 EC EC2003004682A patent/ECSP034682A/es unknown
Also Published As
| Publication number | Publication date |
|---|---|
| KR20030066797A (ko) | 2003-08-09 |
| CN1484642A (zh) | 2004-03-24 |
| CA2431545A1 (en) | 2002-07-11 |
| EP1351955A1 (en) | 2003-10-15 |
| SK8242003A3 (en) | 2004-01-08 |
| HRP20030544A2 (en) | 2004-08-31 |
| CZ20031856A3 (cs) | 2003-09-17 |
| ZA200304311B (en) | 2004-09-02 |
| IL156138A0 (en) | 2003-12-23 |
| MXPA03005981A (es) | 2003-09-10 |
| NO20032973D0 (no) | 2003-06-27 |
| AR035679A1 (es) | 2004-06-23 |
| DZ3460A1 (fr) | 2002-07-11 |
| NZ525821A (en) | 2004-07-30 |
| BR0116672A (pt) | 2003-09-23 |
| NO20032973L (no) | 2003-06-27 |
| JP2004520335A (ja) | 2004-07-08 |
| HUP0302528A2 (hu) | 2003-11-28 |
| PE20020792A1 (es) | 2002-09-06 |
| ECSP034682A (es) | 2003-08-29 |
| EA200300770A1 (ru) | 2003-10-30 |
| TW591023B (en) | 2004-06-11 |
| WO2002053561A1 (en) | 2002-07-11 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| PL374017A1 (en) | Calcitonin gene related peptide receptor antagonists | |
| IL165841A0 (en) | Mchir antagonists | |
| IL157705A0 (en) | Igf antagonist peptides | |
| EP1351933A4 (en) | ANTAGONISTS OF IL-8 RECEPTORS | |
| IL158013A0 (en) | Disease-associated protein | |
| IL163939A0 (en) | Nk1 antagonists | |
| HK1063791A1 (en) | Nk1 antagonists | |
| EP1359915A4 (en) | UROTENSIN-II RECEPTOR ANTAGONISTS | |
| EP1372688A4 (en) | SOMATOSTATIN ANTAGONISTS | |
| EP1409517A4 (en) | FUSION PROTEIN WITH SOMATOSTATIN RECEPTORS | |
| AU2003240705A1 (en) | Morpholinylmethylureas ccr-3 receptor antagonists | |
| AU2002359524A8 (en) | P2x7 receptor antagonists | |
| PT1368032E (pt) | Antagonistas de receptores dos aminoácidos excitadores | |
| PL370367A1 (en) | Ccr-3 receptor antagonists v | |
| IL156138A0 (en) | Excitatory amino acid receptor antagonists | |
| GB0101223D0 (en) | Histamine receptor antagonists | |
| AU2002227020A1 (en) | Pyrrolidinylmethyl- and piperidinyl substituted decahydroisoquinolines as excitatory amino acid receptor antagonists | |
| AU2002228736A1 (en) | Pyrrolidinylmethyl substituted decahydroisoquinolines as excitatory amino acid receptor antagonists | |
| AU6455501A (en) | Excitatory amino acid receptor modulators | |
| GB0306428D0 (en) | Receptor proteins | |
| AU2003219955A1 (en) | Isoquinoline-3-carboxylic acid derivatives as excitatory amino acid receptor antagonists | |
| GB0128161D0 (en) | Receptor protein | |
| AU2001264554A1 (en) | Excitatory amino acid receptor modulators | |
| SI1379239T1 (sl) | N-(2-ariletil)benzilamini, uporabljeni kot antagonisti receptorja 5-ht6 | |
| AU2003212418A8 (en) | Peptide deformylase |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| REFS | Decisions on refusal to grant patents (taken after the publication of the particulars of the applications) |